Health Care & Life Sciences » Biotechnology | 22nd Century Group Inc.

22nd Century Group Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,278.40
529.00
8,522.00
12,280.00
16,600.20
26,426.30
Cost of Goods Sold (COGS) incl. D&A
606.00
961.20
9,876.90
13,551.90
18,255.20
26,869.70
Gross Income
6,672.40
432.20
1,354.90
1,271.90
1,654.90
443.30
SG&A Expense
4,860.00
11,304.80
10,689.00
10,116.00
11,645.00
23,575.30
EBIT
1,812.50
11,737.00
12,043.90
11,387.90
13,299.90
24,018.60
Unusual Expense
27,339.00
3,821.20
1,144.60
29.60
161.40
333.10
Non Operating Income/Expense
-
71.10
15.10
-
-
14,660.50
Interest Expense
748.60
7.10
53.00
37.70
29.10
10.90
Pretax Income
26,275.20
15,595.40
11,031.90
11,581.40
13,029.10
7,966.90
Income Tax
122.00
-
-
-
-
-
Consolidated Net Income
26,153.20
15,595.40
11,031.90
11,581.40
13,029.10
7,966.90
Net Income
26,153.20
15,595.40
11,031.90
11,581.40
13,029.10
7,966.90
Net Income After Extraordinaries
26,153.20
15,595.40
11,031.90
11,581.40
13,029.10
7,966.90
Net Income Available to Common
26,153.20
15,595.40
11,031.90
11,581.40
13,029.10
7,966.90
EPS (Basic)
0.60
0.26
0.16
0.15
0.13
0.06
Basic Shares Outstanding
43,635.20
59,993.40
68,143.30
79,842.80
101,161.40
124,299
EPS (Diluted)
0.60
0.26
0.16
0.15
0.13
0.06
Diluted Shares Outstanding
43,635.20
59,993.40
68,143.30
79,842.80
101,161.40
124,299
EBITDA
1,956.70
11,274.20
11,269.60
10,545.70
12,352.90
22,676.30
Non-Operating Interest Income
-
-
31.20
16.90
115.10
1,069
Equity in Affiliates (Pretax)
-
101.20
95.70
202.30
346.20
-

About 22nd Century Group

View Profile
Address
8560 Main Street
Clarence New York 14221
United States
Employees -
Website http://www.xxiicentury.com
Updated 07/08/2019
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on January 25, 2011 and is headquartered in Clarence, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.